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a b s t r a c t
Trophectoderm cell lines were established from 8-day in vitro-cultured embryos of cattle derived from fertilization (IVF), somatic cell nuclear transfer (NT), or parthenogenetic
activation (P) of in vitro-matured oocytes and from ﬁve 8-day-old in vivo (V) embryos.
The most abundant cellular proteins of 5 V-, 16 NT-, 12 P-, and 16 IVF-derived cell lines
were compared by 2D-gel electrophoresis and mass spectrometry; that is, the unaltered
thiourea/urea extract of each cell culture was analyzed. Common protein spots (n = 118)
were examined, and 95% were identiﬁed with signiﬁcant scores from protein and gene
database searches. Of the proteins detected and identiﬁed, actin and cytokeratin-8 were
found to be the most abundant. Other prominent cellular proteins were metabolic enzymes
such as aldose reductase, phosphoglycerate mutase, enolase, triosephosphate isomerase,
cytoskeletal interacting proteins transgelin and stratiﬁn, anti-oxidant proteins peroxiredoxin 1 and anti-oxidant protein 2, and the calcium-dependent lipid-binding proteins
annexins I and II. In comparative analysis of the 2D-gels, the NT-derived trophectoderm
had less annexins I and II in comparison to the IVF- and P-derived trophectoderm. Because
annexins I and II are abundant in the placenta and have functions important to the maintenance of placentation, the down-regulation of the annexin genes in the cultured NT
trophectoderm may be related to the frequent failures of NT pregnancies.
Published by Elsevier B.V.

1. Introduction
Animal cloning by somatic cell nuclear transfer (NT)
was ﬁrst demonstrated in ungulates (Wilmut et al., 1997;
Cibelli et al., 1998) and is a promising technology with the
potential for increasing the efﬁciency of making precise
modiﬁcations to the mammalian genome. However, as currently practiced 90–98% of NT embryos are lost in utero, and
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at least 20% of offspring resulting from NT experience lethal
developmental abnormalities (De Sousa et al., 2001; Hill et
al., 1999, 2000, 2002). Thus, the incidence of pregnancy failure and developmental abnormalities in NT cattle reduces
the effectiveness of NT as a means of genetic improvement.
The gene expression of embryos and fetuses produced
by normal fertilization with sperm in comparison with
embryos produced by NT shows numerous differences
(Wrenzycki et al., 2001; Nowak-Imialek et al., 2008; Perecin
et al., 2009). Conservation of appropriate DNA methylation patterns appears to be a problem in NT embryos
(Bourc’his et al., 2001; Kang et al., 2002; Cezar et al., 2003;
Santos et al., 2003). Histones and other DNA accessory
proteins which control the form and function of the chro-
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matin are also changed as a result of NT (Tamada et al.,
2006; Laurincik and Maddox-Hyttel, 2007). This incomplete “nuclear reprogramming” that results in the loss of
normal epigenetic modiﬁcations to the DNA may be the
major cause of the developmental failures of NT embryos
(Surani, 2001; Humpherys et al., 2001).
Among the most common of the developmental abnormalities that arise from NT reprogramming errors are
deﬁciencies in placentation or placental hyperplasia (Hill
et al., 2000; Tanaka et al., 2001). The failure to form a
normal placenta may be responsible for many NT pregnancy losses in cattle (Hill et al., 2000; De Sousa et al.,
2001; Hashizume et al., 2002; Lee et al., 2004; Patel et
al., 2004). The trophectoderm is the embryonic tissue that
mediates placental connections with the uterine epithelium, and it was recently reported that DNA methylation
anomalies were speciﬁcally localized to this tissue in NT
cattle embryos (Kang et al., 2002). Also, changes in the
expression of key secretory proteins of trophectoderm have
been found in NT embryos of cattle (Wrenzycki et al., 2001;
Talbot et al., 2008). The analysis of trophectoderm cells
might therefore be useful in determining epigenetic deﬁciencies that lead to placental dysfunction in NT cattle.
Cellular proteins of IVF-, parthenogenote-, NT-, and in
vivo-derived cattle embryos were compared using trophectoderm cell lines derived from each type of embryo.
The use of cell lines enabled the production of relatively
large amounts of embryo-speciﬁc and tissue-speciﬁc sample protein that would otherwise have been very limited
due to the small size of 8-day in vitro-cultured cattle
embryos. Two-dimensional gel (2D-gel) analysis and mass
spectroscopy were applied to determine the proﬁles of
the most abundant proteins in the cultured trophectoderm cells. Among these, at least two proteins, annexin I
and annexin II, were found to be down-regulated in the
NT-derived trophectoderm cell lines. The potential involvement of annexin expression and function in NT pregnancy
failure of cattle is discussed.
2. Materials and methods
2.1. Cell culture and reagents
All cells were grown on 25 cm2 tissue culture ﬂasks
(T25; Greiner, Frickenhausen, Germany). Fetal bovine
serum (FBS) was purchased from Hyclone, Logan UT.
Cell culture reagents were purchased from InVitrogen,
Gaithersburg, MD. Trophectoderm cells were grown on
irradiated STO mouse ﬁbroblast (CRL 1503, American
Type Culture Collection, Rockville, MD) feeder cell layers.
Feeder-layers were prepared by exposing a suspension of
STO cells to 8 Krad of gamma radiation and plating the cells
at 6 × 104 cells/cm2 . STO feeder-layers were maintained by
refeeding every 6–7 days with DMEM supplemented with
4 mM l-glutamine and 10% FBS (10% DMEM). Cultures were
routinely maintained at 37 ◦ C and in a 5% CO2 atmosphere.
2.2. Trophectoderm cell line establishment
In vitro-produced (IVP) blastocysts of cattle derived
from either in vitro maturation, fertilization, and culture

(IVF), or somatic cell nuclear transfer (NT), or parthenogenetic activation (P) were produced from oocytes
obtained from slaughter house ovaries as previously
described (Powell et al., 2004; Talbot et al., 2007a,
2008). Blastocysts of good morphological quality were
used to establish trophectoderm cell lines. Brieﬂy, in vivo
blastocyst-derived cell lines were established from 8-day
“hatched” blastocysts with clearly visible ICMs, obtained
after artiﬁcial insemination (AI) as previously described
in Talbot et al., 2007a. For the AI, sperm collected from
a F1 transgenic Jersey bull was used (Powell et al., 2004;
Talbot et al., 2007a). For NT, IVF, and P cell lines, the blastocysts used were from 8 to 11 days of culture, with the
majority being from 8 to 9 days of culture. IVF blastocysts had usually “hatched” from their zona pellucida. The
zona pellucida of parthenogenetic embryos was rarely ruptured by 8 or 9 days of culture so the trophectoderm cell
lines were usually started from expanded blastocysts with
a very thin zona pellucida. Most of the NT blastocysts had
protruded through the slit in the zona pellucida made by
the enucleation micropipette, and they therefore formed a
typical dumbbell-shaped “hatching” blastocyst. NT blastocysts were produced from two bovine fetal ﬁbroblast cell
lines as the nuclear donor source, and two of the three
GFP expressing NT trophectoderm cell lines were colonycloned 2 times in order to produce a population of cells
that were 100% GFP expressing (see Table 1). To establish blastocyst-derived bovine trophectoderm cell lines,
whole blastocysts were culture on STO feeder cells for 2–3
weeks and primary trophectoderm outgrowths were identiﬁed and isolated as previously described (Talbot et al.,
2000, 2007a, 2008). Primary trophectoderm colonies were
passaged to T25 ﬂasks of STO feeder cells by physical disaggregation and were similarly passaged for 3–12 more times
until established as cell lines, i.e., showed uniform growth
(Talbot et al., 2000). The bovine trophectoderm cell lines
were designated according to the source blastocysts, i.e.,
IVF blastocyst-derived cell lines were designated, FT-, NTderived cell lines, NT-, P-derived cell lines, PT-, and in vivo
blastocyst-derived cell lines, VIVOT.
2.3. Two-dimensional gel electrophoresis of cellular
proteins
Cellular proteins were extracted from a single T25 tissue
culture ﬂask where the cells had reached 75–100% conﬂuency. Generally the period of time to reach this level
of conﬂuency was 1–2 weeks post-passage, but some cultures, particularly at earlier passage levels, were grown
for up to 3 weeks before harvesting for protein. The culture medium was removed by aspiration and ﬂasks were
washed 4 times with ice cold 0.25 M sorbitol solution
(4–5 ml). The ﬁnal sorbitol wash was drained well and
thoroughly aspirated, and the ﬂasks were immediately
frozen and stored at −70◦ C. Flasks were thawed and 1 ml
of lysis buffer (7 M urea, 2 M thiourea, 50 mM DTT, 4%
CHAPS, 0.5% Bio-Lytes) was added to each ﬂask which was
incubated on ice for 20 min. Cells were scraped and disrupted by sonication. Insoluble material was removed by
centrifugation at ∼12,000 × g for 20 min at 22 ◦ C and the
cell lysates were frozen at −80◦ C. The ﬁrst dimension
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Table 1
Biological origins of nuclear transfer-derived trophectoderm cell lines.
Cell line name

Nuclear donor
cell line

a

Oocyte
source

Passage
tested

Comments

NT2-5
NT2-11
NT2-16
NT2-20
NT6-169
NT6-170
NT6-173
NT6-175
NT6-176
NT6-181
NT30-6
NT30-8
NT30-11
GFP-CT-2
GFP-CT-3A1
GFP-CT4-A1

BFF-10
BFF-10
BFF-10
BFF-10
BFF-10
BFF-10
BFF-10
BFF-10
BFF-10
BFF-10
BFF-10
BFF-10
BFF-10
BFF-8
BFF-8
BFF-8

BOMED
BOMED
BOMED
BOMED
BOMED
BOMED
BOMED
BOMED
BOMED
BOMED
MOPAC
MOPAC
MOPAC
MOPAC
MOPAC
MOPAC

P2
P2
P3
P2
P2
P2
P7
P8
P2
P6
P20
P5
P5
P14
P8
P25

2005; b 0.5% FBS donor cell; c G1/G2 egg culture/low O2
2005; b 0.5% FBS donor cell; c G1/G2 egg culture/low O2
2005; b 0.5% FBS donor cell; c G1/G2 egg culture/low O2
2005; b 0.5% FBS donor cell; c G1/G2 egg culture/low O2
2005; b 0.5% FBS donor cell; c G1/G2 egg culture/low O2
2005; b 0.5% FBS donor cell; c G1/G2 egg culture/low O2
2005; b 0.5% FBS donor cell; c G1/G2 egg culture/low O2
2005; b 0.5% FBS donor cell; c G1/G2 egg culture/low O2
2005; b 0.5% FBS donor cell; c G1/G2 egg culture/low O2
2005; b 0.5% FBS donor cell; c G1/G2 egg culture/low O2
2003; b 0.5% FBS donor cell; c G1/G2 egg culture/low O2
2003; b 0.5% FBS donor cell; c G1/G2 egg culture/low O2
2003; d 10% FBS donor cell; c G1/G2 egg culture/low O2
1998; c CR1aa medium egg culture in ambient O2 ; cell line not colony-cloned
1998; c CR1aa medium egg culture in ambient O2 ; cell line colony-cloned 2X
1998; c CR1aa medium egg culture in ambient O2 ; cell line colony-cloned 2X

a
b
c
d

Slaughterhouse ovaries from Bomed Inc., Madison, WI (oocytes matured in transit) or Moyer Packing Co., Philadelphia, PA (oocytes matured in-house).
Nuclear donor cells cultured in medium with 0.5% FBS (“serum-starved”) prior to NT.
See Powell et al. (2004) and Talbot et al. (2007a).
Nuclear donor cells cultured in medium with 10% FBS prior to NT.

isoelectric focusing was performed using 7 cm IPG strips
(pH 3–10, Bio-Rad) in the IPGphor II system (GE Healthcare, Piscataway, NJ). All IPG strips were rehydrated in
the presence of approximately ∼225 g sample protein
in a total volume 125 l rehydration buffer; additional
rehydration buffer contained the following: 8 M urea, 4%
CHAPS, 50 mM DTT, 0.5% Bio-Lytes, 0.001% bromophenol
blue. The strips were passively rehydrated for ∼14 h at rt
and voltage settings for isoelectric focusing were 500 V for
30 min, 1000 V for 30 min, and 8000 V maximum to a total
of approximately 7000 kVh. Second dimension separations
were done as previously described (Talbot et al., 2007b) on
10% polyacrylamide gels (8× 10 cm). The proteins in the gel
were visualized by staining with Colloidal Coomassie Blue
G-250 (Gradipure® ; Life Therapeutics, Frenchs Forest, Australia) and the gel was scanned using laser densitometry
(PDSI, GE Healthcare, Piscataway, NJ). Gels were stored in
a 20% ammonium sulfate solution in seal-o-matic plastic
bags (KAPAK, Minneapolis, MN). Gel images were processed using 2D Elite analytical software (GE Healthcare)
to enumerate and deﬁne individual spots of interest. Spot
volumes were determined using local background for subtraction. All spot volume and relative spot volume values
(relative to aldose reductase or relative to phosphoglycerate mutase) were analyzed by GLM ANOVA (NCSS 2000,
Kaysville, UT) and signiﬁcant differences were separated
by Fisher’s LSD multiple-comparison test. In each graph
(Fig. 6), mean values with different letters are different
(P < 0.05). Error bars are the standard error of the means.

2.4. MALDI-TOF-MS analysis of tryptic peptides
A Voyager DE-STR MALDI-TOF mass spectrometer (Applied Biosystems, Framingham, MA) operated
in positive ion reﬂector mode was used to analyze
tryptic peptides. Samples were co-crystallized with ácyanohydroxycinnamic acid (CHCA) matrix, and spectra
were acquired with 50 shots of a 337 nm Nitrogen Laser

operating at 20 Hz. Spectra were calibrated using the
trypsin autolysis peaks at m/z 842.51 and 2211.10 as internal standards.

2.5. MS/MS analysis of tryptic peptides
A Thermo Finnigan LCQ Deca XP plus Ion Trap mass
spectrometer was used to analyze proteins that were not
positively identiﬁed by MALDI-TOF mass spectrometry.
Peptides were separated on a reverse phase column using
a 30 min gradient of 5–40% acetonitrile:water containing
0.1% formic acid. Following a survey scan from 300 to
2000 Da, MS/MS spectra were acquired on the three most
abundant ions identiﬁed in the survey scan. Dynamic exclusion was employed to prevent the continuous analysis of
the same ions. The raw data was processed by Sequest to
generate DTA ﬁles for database searching. The merge.pl
script from Matrix science was used to convert multiple
Sequest DTA ﬁles in to a single mascot generic ﬁle suitable
for searching in Mascot.
Protein identiﬁcation was performed by searching the
NCBI non-redundant database using the Mascot search
engine (http://www.matrixscience.com), which uses a
probability based scoring algorithm. The following variables were used for database searches with MALDI-TOF
peptide mass ﬁngerprinting data: monoisotopic mass,
25 ppm mass accuracy, trypsin as digesting enzyme with
1 missed cleavage allowed, oxidation of methionine,
N-terminal pyroglutamic acid from glutamic acid or glutamine as allowable variable modiﬁcations. For database
searches with MS/MS spectra the following parameters
were used, average mass, 1.5 Da peptide and MS/MS mass
tolerance, peptide charge of +1, +2, or +3, trypsin as digesting enzyme with 1 missed cleavage allowed, oxidation of
methionine, N-terminal pyroglutamic acid from glutamic
acid or glutamine as allowable variable modiﬁcations. Taxonomy was limited to mammals for both MALDI and
MS/MS ion searches. For MALDI-TOF-MS data to qualify as
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a positive identiﬁcation, a protein’s score had to equal or
exceed the minimum signiﬁcant score. Positive identiﬁcation of proteins by MS/MS analysis required a minimum
of two unique peptides, with at least one peptide having a
signiﬁcant ion score.
3. Results
Fig. 1 shows the typical appearance of primary bovine
trophectoderm cultures and cell lines at low magniﬁcation, and of the trophectoderm cells at high magniﬁcation.
As previously shown, IVF- and NT-derived primary outgrowths occur at a similar success rate, P-derived primary
outgrowths occur at a lower rate (Talbot et al., 2008).

Fig. 1. Examples of trophectoderm of cattle in primary culture and
established cell lines. (A) IVF bovine blastocyst’s primary trophectoderm
outgrowth after 10 days of culture on STO feeder cells. Magniﬁcation ≈ 35×. Arrows indicate borders of the primary colony. (B) Bovine
trophectoderm cell line (VIVOT-199) growing in a T25 ﬂask on STO feeder
cells at passage 15. Arrow indicates individual colony among many that
form after each physical disaggregation passage. Magniﬁcation ≈ 20×. (C)
Phase-contrast micrograph of bovine trophectoderm cells of the in vivoderived VIVOT-199 cell line at 300× magniﬁcation. Note dome formation
lower right (arrows).

Fig. 2. 2D-gels of the PT28-2 parthenogenetic trophectoderm cell line cellular proteins and of STO feeder cell cellular proteins. Annexin I, annexin
II, aldose reductase, actin, and cytokeratin 8 are indicate in the PT28-2
gels. Loading was more than 6-fold that present in trophectoderm cell
line samples for the STO feeder cell sample.
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Table 2
Trophectoderm abundant cellular proteins of cattle identiﬁed by MALDI-TOF and LC–MS/MS.
Spot
ID #

MW

PI

Protein ID
Chain A,
beta-actin–proﬁlin
complex [Bos taurus]
Creatine kinase,
mitochondrial 1
(ubiquitous) [Bos
taurus]
Heterogeneous nuclear
ribonucleoproteins
A2/B1 (hnRNP
A2/hnRNP B1) isoform
7 [Bos taurus]
Galectin-3
(galactose-speciﬁc
lectin 3) [Bos taurus]
Coﬁlin 1 (non-muscle)
[Homo sapiens]
Keratin 8 [Bos taurus]
Enolase 1 [Bos taurus]
Stratiﬁn [Ovis aries]
Aldose reductase (EC
1.1.1.21) [Bos taurus]
Annexin A2 [Bos taurus]
(Muscle-type aldolase)
isoform 2 [Bos taurus]
Glyceraldehyde-3phosphate
dehydrogenase [Bos
taurus]
Annexin I [Bos taurus]
Carbonic anhydrase II
[Bos taurus]
Transgelin 2 [Bos
taurus]
Keratin 10 [Homo
sapiens]
Peptidyl-prolyl
cis-trans isomerase A
(EC 5.2.1.8) (PPIase A)
(rotamase A)
(cyclophilin A)
(cyclosporin A-binding
protein) [Bos taurus]
Phosphoglycerate
mutase 1 (brain)
[Homo sapiens]
Triosephosphate
isomerase [Bos taurus]
Anti-oxidant protein 2
(non-selenium
glutathione
peroxidase, acidic
calcium-independent
phospholipase A2) [Bos
taurus]
Heat shock 27 kDa
protein 1 [Bos taurus]
Peroxiredoxin-1 [Bos
taurus]
Transketolase [Bos
taurus]
Protein
disulﬁde-isomerase
(EC 5.3.4.1) ER60
precursor [Bos taurus]
Cytokeratin 8 (370 AA)
[Bos taurus]

31

41,664

5.15

33

47,266

8.6

34

35,791

8.67

35

27,686

8.87

36

18,730

8.22

37
38
39
40

53,552
47,639
27,946
36,319

5.7
6.37
4.65
5.76

41
44

38,873
39,411

6.92
8.45

45

35,714

8.52

47
48

38,927
29,096

6.37
6.41

52

22,412

8.39

53

58,792

5.09

54

17,727

8.37

56

28,802

6.67

57

26,673

6.45

58

25,051

6

59

22,665

5.77

60

22,195

8.59

75

67,863

7.56

76

54,939

6.51

77

42,369

5.13

a

Peptides
matched

b
Sequence
coverage

c
Mowse
score

d

Expected
value

NCBI

Method

0.00068

gi|2624850

MALDI

9

29%

89

15

29%

119

6.10E−07

gi|73587293

MALDI

13

46%

111

3.90E−06

gi|76662749

MALDI

8

28%

111

3.90E−06

gi|76668658

MALDI

3

19%

203

gi|15147369

MS/MS

29
11
11
8

50%
27%
37%
21%

307
132
78
312

1.00E−25
3.30E−08
0.0051

gi|75812916
gi|87196501
gi|3249019
gi|113594

MALDI
MALDI
MALDI
MS/MS

23
11

58%
35%

233
107

1.40E−18
1.00E−05

gi|27807289
gi|76653611

MALDI
MALDI

6

20%

62

0.03

G3P BOVIN

MALDI

12
9

35%
37%

144
116

2.10E−09
1.30E−06

gi|73853762
gi|30466252

MALDI
MALDI

11

49%

133

2.50E−08

gi|61888874

MALDI

15

29%

81

0.0039

gi|40354192

MALDI

7

44%

108

7.50E−07

PPIA BOVIN

MALDI

12

50%

79

0.0062

gi|38566176

MALDI

11

44%

80

0.0048

gi|61888856

MALDI

10

45%

99

6.10E−05

gi|27807167

MALDI

14

54%

199

6.40E−15

gi|71037405

MALDI

13

40%

188

8.00E−14

gi|66773956

MALDI

12

20%

127

1.10E−07

gi|51491841

MALDI

26

50%

276

1.40E−22

gi|1083063

MALDI

28

70%

318

8.80E−27

gi|481

MALDI
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Table 2 (Continued )
Spot
ID #

MW

PI

Protein ID

a

Peptides
matched

b
Sequence
coverage

c
Mowse
score

d

Expected
value

NCBI

Method

Tubulin, beta
polypeptide [Homo
sapiens]
Chain E, bovine
F1-ATPase [Bos taurus]
Gelsolin-like capping
protein [Bos taurus]
Galactose mutarotase
(aldose 1-epimerase)
[Bos taurus]
Cytokeratin 19 [Bos
taurus]
Tropomyosin 1-alpha
chain isoform 5 [Homo
sapiens]
Tropomyosin alpha-4
chain (tropomyosin-4)
(platelet beta
tropomyosin)
Chain A, carbonic
anhydrase II [Bos
taurus]
Glutathione-Stransferase pi [Bos
taurus]
Phosphatidylethanolamine
binding protein [Bos
taurus]
Chain A, mitochondrial
F1-atpase [Bos taurus]
Fascin homolog 1,
actin-bundling protein
[Bos taurus]
Hypothetical protein
LOC617109 [Bos taurus]
Albumin [Bos taurus]
Heat shock 70 kDa
protein 9B (mortalin-2)
[Bos taurus]
Hypothetical protein
LOC507345 [Bos taurus]
Tumor rejection
antigen (gp96) 1 [Bos
taurus]
Annexin A8 [Bos taurus]
Purine nucleoside
phosphorylase [Bos
taurus]
Keratin 9 [Homo
sapiens]
Predicted: similar to
vinculin isoform
meta-VCL isoform 1
[Bos taurus]
Procollagen-proline,
2-oxoglutarate
4-dioxygenase [Bos
taurus]
Cathepsin D {EC
3.4.23.5} [Bos taurus]
Heterogenous nuclear
ribonucleoprotein
A2/B1 [Mus musculus]
Voltage-dependent
anion channel 1 [Bos
taurus]
GNB2L1 protein [Bos
taurus]

17

35%

129

7.00E−08

gi|57209813

MALDI

15

44%

108

8.80E−06

gi|3660252

MALDI

9

25%

90

0.00062

gi|30466254

MALDI

10

34%

80

0.0062

gi|77736588

MALDI

24

67%

306

1.40E−25

gi|62751472

MALDI

22

47%

175

1.80E−12

gi|27597085

MALDI

18

43%

168

8.80E−12

gi|20178270

MALDI

7

32%

104

2.20E−05

gi|46016008

MALDI

5

39%

70

0.051

gi|29135329

MALDI

8

58%

87

0.0011

gi|4389366

MALDI

15

41%

89

0.00065

gi|1943080

MALDI

10

27%

111

4.40E−06

gi|78045491

MALDI

28

44%

170

5.60E−12

gi|78369310

MALDI

14
26

22%
47%

111
206

4.30E−06
1.40E−15

gi|30794280
gi|77735995

MALDI
MALDI

35

41%

178

8.60E−13

gi|77735541

MALDI

34

38%

218

8.60E−17

gi|27807263

MALDI

18
11

52%
46%

214
84

2.20E−16
0.0019

gi|27806317
gi|61553356

MALDI
MALDI

16

26%

100

6.10E−05

gi|55956899

MALDI

15

17%

72

0.036

gi|119918578

MALDI

19

37%

239

6.80E−19

gi|27806501

MALDI

11

30%

101

4.40E−05

gi|299522

MALDI

17

52%

170

5.50E−12

gi|3329498

MALDI

14

53%

121

4.40E−07

gi|73853754

MALDI

5

10%

242

gi|74354951

MS/MS

78

47,736

4.7

78

51,397

4.97

79

38,852

6.17

80

37,591

5.89

81

43,858

4.92

82

32,846

4.69

83

28,505

4.65

84

28,965

6.4

85

23,598

6.89

86

20,714

6.62

87

55,199

8.27

88

54,751

6.55

89

62,442

6.08

90
91

69,278
73,696

5.82
5.97

93

89,274

5.13

94

92,369

4.76

95
96

36,764
32,006

5.3
5.92

97

62,027

5.14

99

12,3787

5.58

100

57,230

4.8

102

37,687

5.43

103

35,971

8.67

105

30,821

8.82

106

38,327

8.09
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Table 2 (Continued )
Spot
ID #

MW

a

PI

Protein ID

Voltage-dependent
5
anion channel 2 [Homo
sapiens]
Annexin V = CaBP37
21
isoform [Bos taurus]
Predicted: similar to
8
cytoplasmic beta-actin
isoform 2 [Macaca
mulatta]
Tyrosine 314
monooxygenase/tryptophan
5-monooxygenase
activation protein, zeta
polypeptide [Homo
sapiens]
Beta-actin [Lama
7
glama]
Laminin-binding
4
protein [Homo sapiens]
B23 nucleophosmin
7
(280 AA) [Homo
sapiens]
Acidic ribosomal
10
phosphoprotein PO
[Bos taurus]
Capping protein (actin
6
ﬁlament) muscle
Z-line, beta [Bos taurus]
Chain B, E-trypsin
3
(E.C.3.4.21.4) [Sus
scrofa]
Biliverdin reductase B
7
(ﬂavin reductase
(NADPH)) [Bos taurus]
ALB protein [Bos
9
taurus]
Translationally
7
controlled tumor
protein (TCTP)
Myosin: regulatory
8
light chain
Peroxiredoxin 5
7
precursor [Bos taurus]
Ubiquitin-conjugating
2
enzyme E2N
Villin 2 [Bos taurus]
28
Gelsolin
5
Similar to 60 kDa heat
15
shock protein,
mitochondrial
precursor (Hsp60)
(60 kDa chaperonin)
(CPN60) (heat shock
protein 60) (HSP-60)
Similar to LOC512571
12
protein [Bos taurus]
Fumarate hydratase,
2
mitochondrial
(fumarase)
Asparaginase-like 1
5
protein [Bos taurus]
Acetyl-coenzyme A
5
acetyltransferase 2 [Bos
taurus]
Lactate dehydrogenase
13
A [Bos taurus]
Rho GDP dissociation
9
inhibitor (GDI) alpha
[Bos taurus]

107

30,329

8

108

35,935

4.86

109

28,193

5.2

110

27,696

4.73

111

33,716

5.26

112

31,774

4.84

112

30,919

4.71

113

32,356

5.28

114

33,720

6.02

115

88,14

6.67

116

22,118

6.58

117

69,190

5.88

118

19,525

4.9

119

19,635

4.71

121

23,196

8.62

122

17,127

6.13

125
126
127

68,717
86,014
60,957

6.06
5.76
5.78

127

58,423

7.96

128

49,978

7.01

129

32,030

7

131

41,144

6.46

132

36,574

8.12

133

23,407

5.12

Peptides
matched

b
Sequence
coverage

c
Mowse
score

d

Expected
value

NCBI

Method

0.052

gi|57209199

MALDI

1.10E−15

gi|260138

MALDI

0.00023

gi|109119055

MALDI

2.20E−06

gi|68085578

MALDI

0.2

gi|29603621

MALDI

19%

68

64%

207

31%

94

55%

114

29%

64

16%

290

gi|34234

MS/MS

15%

259

gi|825671

MS/MS

37%

83

0.003

gi|2293577

MALDI

13%

68

0.087

gi|28603770

MALDI

46%

44

gi|999627

MALDI

43%

78

0.0089

gi|27806297

MALDI

14%

61

0.47

gi|74267962

MALDI

46%

71

0.04

gi|6175056

MALDI

51%

117

1.10E−06

gi|228542

MALDI

34%

72

0.036

gi|27807445

MALDI

11%

98

gi|4507793

MS/MS

41%
5%
31%

217
161
101

4.40E−05

gi|27806351
gi|51854227
gi|74005078

MALDI
MS/MS
MALDI

29%

75

0.019

gi|119902010

MALDI

4%

111

gi|120604

MS/MS

14%

298

gi|116004289

MS/MS

12%

206

gi|109659291

MS/MS

36%

138

9.10E−09

gi|27806559

MALDI

43%

106

1.40E−05

gi|28603774

MALDI

20

1.10E−16
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Table 2 (Continued )
Spot
ID #

MW

PI

Protein ID

a

Peptides
matched

b
Sequence
coverage

c
Mowse
score

d

Expected
value

NCBI

Method

Eukaryotic translation
elongation factor 2 [Bos
taurus]
T-complex protein 1
subunit alpha
(TCP-1-alpha)
(CCT-alpha) (65 kDa
antigen) Chinese
hamster
Pyruvate kinase [Bos
taurus]
Chain A, crystal
structure of bovine
Hsc70(Aa1554)e213aD214A
mutant
Chain A, mitochondrial
Ef-Tu
GDP dissociation
inhibitor 2 [Bos taurus]
Proteasome (prosome,
macropain) 26S
subunit, ATPase 2
[Rattus norvegicus]
ARP3 actin-related
protein 3 homolog
(yeast) [Bos taurus]
Calreticulin, brain
isoform 1 [Bos taurus]
Chaperonin containing
TCP1, subunit 2 (beta)
[Rattus norvegicus]
Predicted: similar to
TIP49 [Bos taurus]
Vimentin [Mus
musculus]
Aldo-keto reductase
family 1, member A1
(aldehyde reductase)
[Bos taurus]
Psmc6 protein [Rattus
norvegicus]
Sorbitol
dehydrogenase [Bos
taurus]
Isocitrate
dehydrogenase 1
(NADP+), soluble [Bos
taurus]
Chain A,
beta-actin–proﬁlin
complex
Prohibitin [Mus
musculus]
Chain A, structure of
human muscle
pyruvate kinase
(Pkm2)
Predicted: similar to
LOC512571 protein
[Bos taurus]
IMP (inosine
monophosphate)
dehydrogenase 2 [Bos
taurus]
TSH receptor
suppressor
element-binding
protein-1; TSEP-1
[Rattus sp.]

16

18%

129

7.20E−08

gi|115497900

MALDI

12

22%

94

0.00024

gi|135536

MALDI

10

21%

85

0.0016

gi|73587283

MALDI

14

27%

111

4.50E−06

gi|78101017

MALDI

14

38%

156

1.40E−10

gi|6137414

MALDI

16

35%

155

1.80E−10

gi|76253900

MALDI

13

28%

80

0.0059

gi|15100181

MALDI

10

21%

109

7.20E−06

gi|115304856

MALDI

11

15%

103

4.31

gi|631545

MALDI

14

35%

114

2.30E−06

gi|54400730

MALDI

10

30%

79

0.0076

gi|119914925

MALDI

31

64%

333

2.90E−28

gi|31982755

MALDI

9

27%

108

9.10E−06

gi|115495641

MALDI

12

37%

120

5.70E−07

gi|81294202

MALDI

6

24%

70

0.059

gi|82617550

MALDI

18

49%

148

9.10E−10

gi|75832090

MALDI

10

32%

71

0.034

gi|576368

MALDI

8

36%

82

0.0038

gi|6679299

MALDI

11

20%

77

0.012

gi|67464392

MALDI

15

34%

98

8.70E−05

gi|119902010

MALDI

15

31%

120

5.70E−07

gi|77735779

MALDI

11

31%

71

0.031

gi|9653686

MALDI

135

95,307

6.41

136

60,301

5.71

137

61,389

8.62

139

60,863

6.05

140

43,702

6.09

142

50,456

5.94

143

48,544

5.59

144

47,283

5.71

146

46,353

4.31

148

57,422

6.01

149

50,122

6.02

153

53,655

5.06

155

36,594

6.8

159

43,261

7.23

160

38,075

7.14

162

46,729

6.13

163

41,801

5.21

166

29,802

5.57

171

59,707

8.22

172

58,423

7.96

173

55,728

6.87

175

35,509

9.77
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Table 2 (Continued )
Spot
ID #

MW

PI

Protein ID

a

Peptides
matched

b
Sequence
coverage

Predicted: similar to
Glycerol-3-phosphate
dehydrogenase 1-like
[Bos taurus]
Chain A, crystal
structure of
phosphorylationmimicking mutant T6d
Of annexin IV
Predicted: similar to
tropomyosin 3 isoform
2 isoform 3 [Canis
familiaris]
PRDX5 protein [Bos
taurus]
Actin-related protein
2/3 complex, subunit 5,
16 kDa [Bos taurus]

10

27%

92

14

42%

14

178

38,214

6.13

180

35,749

5.41

181

17,582

4.74

216

17,351

5.92

218

16,220

5.87

c
Mowse
score

d

Expected
value

NCBI

Method

0.00034

gi|119914253

MALDI

128

9.10E−08

gi|14278334

MALDI

52%

156

1.40E−10

gi|73961067

MALDI

9

50%

132

3.60E−08

gi|74354725

MALDI

7

51%

88

0.00093

gi|78369476

MALDI

a

Peptides matched refers to the number of peptides identiﬁed from the primary sequence.
Sequence coverage refers to the percentage of the protein sequence represented by the matched peptides.
c
MOWSE score is the absolute probability that the observed match is a random event expressed as −10 × log10 (P), where P is the absolute probability
(Pappin et al., 1993).
d
The number of times one would expect to obtain an equal or higher score, purely by chance; analogous to P-value.
b

Fig. 3. Representative 2D-gel of trophectoderm cellular proteins from cell line NT30-11 with enumeration of the protein spots listed in Table 2.
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Fig. 4. Replicate 2D-gels runs (n = 4) of the cellular proteins from cell
line NT2-16 at two passage levels and from frozen/thawed samples or
unfrozen samples.

There was no difference noted in the success rate of cell
line establishment from any of the sources of blastocysts,
except that the in vivo-derived blastocysts produced cell
lines with 100% efﬁciency, well above that of the IVP blastocysts (Talbot et al., 2007a). However, the number of in
vivo blastocysts obtained was small in comparison to the
number of IVP blastocysts (Talbot et al., 2007a). In total,
16 NT-, 12 P-, 16 IVF- and 5 in vivo-derived cell lines were
compared by 2D-gel electrophoresis in the study. Details
of the origins of the NT cell lines are brieﬂy summarized in
Table 1.
The proteins from the untreated, non-fractionated samples of each trophectoderm cell line, harvested from 1 T25
ﬂask each, were separated by 2D-gel electrophoresis, e.g.,
Fig. 2, and the protein spots were analyzed and identiﬁed by mass spectroscopy (Table 2; Fig. 3). Fig. 2 shows
the 2D-gel protein proﬁle of PT28-2, a parthenogenetic
blastocyst-derived trophectoderm cell line, and it is typical of all the cell lines. Because no more than 225 g of
total protein could be loaded on a 7-cm IPG strip without
hampering the electrophoretic separation of the proteins
(Table 2), is a compellation of the most abundant trophectoderm proteins that have been identiﬁed to date. Replication
of 2D-gel separations was observed in four independent
gel runs from two independent sample preparations of the
NT2-16 cell line (Fig. 4). Fig. 4 shows a close-up view of
the same area of the gels containing three principle spots;
annexin I (spot # 47), annexin II (spot # 41), and aldose
reductase (spot # 40). STO feeder cell protein was a minor
component of the total protein harvested from each T25
ﬂask of the trophectoderm cell lines. That STO feeder cell
proteins are a minor proportion of the visible protein spots
is apparent from Fig. 2 which shows a 2D-gel where more

than 6 times as much sample from an STO feeder cellonly T25 ﬂask was electrophoretically separated (based on
equivalent trophectoderm cell line sample volume). Also,
data base species identiﬁcation was often speciﬁc for cattle but not cells of mice (STO cells are mouse ﬁbroblasts,
Table 2). Extensive visual inspections of the gels were conducted to see if any of the cellular proteins varied according
to the type of blastocyst the cell lines originated from and
this was conﬁrmed by densitometry and 2D-gel-spot software analysis. The comparison of the gels indicated two
proteins, identiﬁed as annexin I (spot # 47) and annexin
II (spot # 41), were different when comparing FT and P
cell lines to NT cell lines. A side-by-side comparison of the
portion of the gel containing the annexin I, annnexin II,
and aldose reductase proteins from the 16 NT-, 16 IVF-,
12 P-, and 5 in vivo-derived cell lines (VIVOT-) is shown
in Fig. 5. Annexin I content is clearly reduced in, or absent
from, the NT-derived cell lines in comparison to the IVF-,
parthenogenetic-, and in vivo-derived cell lines (designated
FT, PT, and VIVOT, respectively). Annexin II protein spots
were also reduced in the NT-derived cell lines although this
was not as apparent from visual inspection. Densitometry
measurements of the three proteins from all the gels veriﬁed that both annexins I and II were reduced (P ≤ 0.05)
in the NT trophectoderm cell lines when compared to the
internal less variant control proteins, aldose reductase and
phosphoglycerate mutase (Fig. 6). The absolute values of
annexins I and II were not different (P ≤ 0.05) between NTand in vivo-derived cell lines probably because of the small
sample size of VIVOT cell lines (n = 5). However, by visual
inspection, 4 out of the 5 VIVOT cell lines had annexin I,
and 5 out of 5 had annexin II (Fig. 5). A difference (P ≤ 0.05)
was found for annexin I when normalized to aldose reductase or phosphoglycerate mutase, two less variant proteins
(Fig. 6).
4. Discussion
Modulation of annexins, and also of S100 protein
family members that interact with some annexins, has
been observed in proteomic surveys of cow and pig NT
placentas and human placenta. Kim et al., 2005, found
down-regulation of annexin I in term NT placentas of cattle when compared to normal control placentas. In 26-day
pig NT extraembryonic tissue, annexins I, II, and IV were
up-regulated in comparison to the extraembryonic tissue
from fetuses of normally bred sows (Chae et al., 2006). In
term pig NT placenta, proteomic analysis again showed upregulation of annexins I and IV (V and VIII, also) compared
to normal controls, but annexin II was down-regulated (Lee
et al., 2007). A few proteomic studies have investigated
human placental tissues, either from in vivo samples, or
in vitro samples from primary tissue cultures of cytotrophoblast cells as a model of trophectoderm differentiation
and function. In an in vitro differential oxygen model of
cytotrophoblast differentiation and invasion, Hoang et al.
(2001), found that the amount of annexin II in the cells
increased under hypoxic conditions. In another in vitro
study of human cytotrophoblast cells involving the modeling of the role of neurokinin-B (NKB) in preeclampsia,
annexin II and the annexin I partner protein, S100A11
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Fig. 5. Side-by-side comparison of that portion of all the gels containing annexins I and II, and aldose reductase. NT cell lines designated GFP-CT were from
blastocysts expressing the GFP gene.
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Fig. 6. Comparison of the means of densitometry measurements of the proteins spots of annexins I and II, or when normalized to the densitometry of
aldose reductase and phosphoglycerate mutase, in 2D-gels of the proteins of NT-, FT-, PT-, and in vivo-derived (INV) bovine trophectoderm cell lines.

(calgizzarin; Streicher et al., 2009), were both downregulated in response to NKB treatment (Sawicki et al.,
2003). Annexin I binding partner, S100A11 protein, was
also found to be down-regulated in the placental villous tissue of women suffering from early loss of pregnancy (Liu et
al., 2006). Together, these previous proteomic studies and
results from the present research, associate annexins I and

II, and their S100 partner proteins, with pathophysiological conditions or responses in the placenta and with NT
placentas.
Although the speciﬁc roles of annexins in the physiology
of placentation and pregnancy are not well understood to
date, various studies draw attention to their involvement
in placental function and parturition (Myatt et al., 1992;
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Bogic et al., 1999). The location and function of annexins
have been studied mainly in human and rodent placentas or in in vitro models thereof. The placenta is a rich
source of annexins, one study estimating that the annexins make up 2% of the total placental membrane proteins
(Buhl et al., 1991), and annexins I and II can be readily
puriﬁed from placental tissue (Moore et al., 1992). Why
placental tissue contains so much and so many annexins is
also not understood. At least one annexin family member,
annexin V, is important to placental function and integrity,
and this appears to be due to its anti-coaggulation activity on the surface of the syncytiotrophoblast cells (Wang et
al., 1999). Annexins I and II are in greater amounts in the
amnion, chorion, and trophoblast cells (Myatt et al., 1992;
Kristoffersen and Matre, 1996; Sun et al., 1996; Bogic et al.,
1999). Annexin I, a/k/a lipocortin I, is a calcium-dependent
phospholipid-binding protein that may stimulate or inhibit
phospholipase A2 (PLA2 ) and thus inﬂuence the production
of arachidonic acid and subsequently prostaglandin production in the trophoblast and, possibly, the endometrium
through a potential paracrine mode of action (Bennett
et al., 1994; Aarli et al., 1997). Prostaglandin synthesis, that can participate in an inﬂammatory response
or in a maternal “recognition of pregnancy” response
might, therefore, be inﬂuenced by annexin I in the periimplantation embryo’s trophoblast tissue (Lawrence et al.,
2002; Gavins et al., 2005; Meier et al., 2008). Also, annexin
II, a/k/a lipocortin II or calpactin I, is involved with PLA2
activity and prostaglandin synthesis through its interaction
with protein S100A10 (Wu et al., 1997; Akiba et al., 2000).
Potentially as important, however, is that annexin II in conjunction with the S100A10 protein, has been identiﬁed as
the receptor for tissue plasminogen activator (tPA), and as
such, is involved in extracellular matrix (ECM) remodeling
via activation of cell surface bound plasminogen to plasmin,
and subsequently activation of matrix metaloproteinases
(Hajjar and Hamel, 1990; Bogic et al., 1999). Because ECM
remodeling and adjustments of cellular architecture are
important in establishing the intimate fetomaternal connection in the placentomes of ruminants, down-regulation
of annexin II might lead to placentome failure in NT fetuses
(Hashizume et al., 2002; Hirata et al., 2003; Hoffert et al.,
2005; Pfarrer, 2006). Further, both annexins I and II directly
affect the migratory behavior of epithelial cells in several
cancer cell models, and down-regulation of these annexins causes a loss of cell migration and “invasiveness”, as
measured by in vitro assay (Ling et al., 2004; Liu et al.,
2003; Babbin et al., 2006). So, again, it is possible that
down-regulation of annexins I and II in the trophoblast
of NT embryos hampers cotyledonary interaction with the
maternal caruncles due to inhibition of trophoblast cellmediated ECM remodeling and cell migratory processes
(Ling et al., 2004; Liu et al., 2003; Babbin et al., 2006).
Further investigations are necessary to conﬁrm the
observation of the lesser amounts of annexins I and II
in the cultured trophectoderm cells of NT embryos. First,
because all of the NT trophectoderm cell lines in the study
were derived from NT embryos created with Jersey cattle fetal ﬁbroblasts (BFF-8 and BFF-10 nuclear donor cells;
see Powell et al., 2004 and Talbot et al., 2007a) further
comparative examinations are warranted. For example, NT
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trophectoderm cell lines could be created with nuclear
donor cells from other cattle breeds and their protein
proﬁles similarly analyzed by 2D-gel electrophoresis. This
might identify if Jersey cattle trophectoderm cells are naturally low in annexins I and II—although in the present study
the AI-derived trophectoderm cell lines were from Holstein
cows inseminated with Jersey semen and all ﬁve had high
levels of annexin II and four of the ﬁve had high levels of
annexin I. Secondly, the analysis of NT trophectoderm cell
lines created from NT embryos made with donor nuclei
from several more independent fetal ﬁbroblast cell lines
needs to be performed. This would clarify the possibility
that the down-regulation of annexin I and II genes might
only be associated with the use of certain nuclear donor
cell lines, or, by extension, certain cell types, e.g., ﬁbroblast
compared to epithelial nuclear donor cells. Third, a comparison of annexins I and II in intact IVP embryos, ideally
NT and IVF embryos developed in vivo to the ﬁlamentous
stage and in comparison to matched AI embryos, needs to
be performed to ascertain that the down-regulated expression of annexins I and II observed in the in vitro-cultured
trophectoderm is also present in the in vivo trophectoderm
of the early peri-implantation embryo.
If the same aberration in annexins I and II levels is
observed with in vivo-developed trophectoderm tissue,
regardless of donor cell breed or embryo source, the annexins might serve as markers for monitoring embryo ﬁtness or
for monitoring modiﬁcations to NT methodology to make
NT embryos more ﬁt, i.e., to see if aberrant annexin levels
could be changed to the “normal” levels of IVF embryos.
Because NT methodology will always be in vitro, the protein proﬁle of in vitro-produced embryos that establish
pregnancies at “state of the art” efﬁciency, i.e., 40–50%,
is the appropriate comparative positive control. However,
differences in protein proﬁle that can be elucidated in comparison to in vivo-derived embryos or embryonic tissue will
always be of value in understanding basic developmental
biology and fetomaternal interaction. In any case, embryo
transfers of putatively “improved NT embryos” could then
test the assumption that NT embryos with IVF-like protein proﬁles will in fact have greater ﬁtness for survival and
development to term. Also tested would be the major corollary to this assumption that the protein proﬁle at the early
blastocyst stage of development, prior to embryo transfer,
will be a good indicator of successful reprogramming for
later stages of development, i.e., will normal early gene
expression translate to normal gene expression during all
stages of development? The available literature does not
answer this question (Hashizume et al., 2002). Abnormal
proteins levels in NT embryos may also provide “markers” for the assessment of nuclear reprogramming that can
be used for the creation of rapid, non-destructive assays
of embryo ﬁtness. Currently there are no real-time procedures for assessing whether a nuclear cloned embryo
is properly “reprogrammed” for normal developmental
gene expression prior to its transfer into the surrogate
mother. Immunocytochemical, anti-viral assay, or ELISA
based comparisons of individual NT, IVF, and P embryos
might be devised and tested for this purpose from genomic
and proteomic data, e.g., Kato et al. (2007) and Talbot et
al. (2008). Finally, the proteomic analysis of the trophec-
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toderm cell lines of cattle, as it continues, will develop
a database from which comparative analyses can be performed from other related proteomic and genomic studies
to broaden the fundamental knowledge of developmental
biology and reproductive physiology.
The 2D-gel electrophoresis of the total thiourea/urea
extracted cellular proteins of the trophectoderm cell lines
resolved protein spots representing the most abundant
proteins in the crude cell lysate. To identify the many
thousands of proteins that must actually comprise the cell
lysates, fractionation of the total cell lysate (or the use of
subcellular organelle preparations) must be done to drastically reduce the percentage content of proteins such as
actin and cytokeratin-8, which, because of their abundance,
preclude loading enough protein on the IPG strips to see
the less abundant proteins. From 149 spots selected and
analyzed by mass spectroscopy, 104 unique proteins were
identiﬁed. Some of the protein spots that were analyzed
contained mixtures of proteins and will require greater
electrophoretic resolution in one or both dimensions to
resolve. Also, some were not identiﬁable in the protein
data bases, but the data bases are always improving over
time. In any case, many of the proteins were in common
with those reported in proteomic analyses of the in vivo
tissues of ungulate NT placentas and of human placentas or cytotrophoblast cells (Hoang et al., 2001; Sawicki et
al., 2003; Kim et al., 2005; Lee et al., 2007; Zhang et al.,
2008). As discussed above, annexins I and II were found in
the samples of trophectoderm cell lines, but also, annexins
V and VIII were found. Proteins found the most frequently represented metabolic/cytosolic enzymes such as
lactate dehydrogenase, creatine kinase, aldose reductase,
phosphoglycerate mutase, enolase, triosephosphate isomerase, carbonic anhydrase, glyceraldehyde-3-phosphate
dehydrogenase, aldehyde reductase, triosephosphate isomerase, and transketolase. The most abundant proteins
were cytoskeletal proteins such as actin, tubulin, myosin,
cytokeratin-8, -9, -18, and -19, and cytoskeletal interacting
proteins such as tropomyosin, proﬁlin, villin, coﬁlin, gelsolin, transgelin and stratiﬁn. The intermediate ﬁlament
protein, vimitin, was also found but was species identiﬁed as Mus musculus, and, therefore, was probably from
the STO feeder cell protein component of the cell lysate.
Chaperone or stress proteins such as heat shock proteins
and TCP1 subunit 2 were found, and anti-oxidant proteins
such as peroxiredoxin 1, peroxiredoxin 5, anti-oxidant
protein 2, and glutathione-S-transferase were present.
Finally, protein-degradation proteins such as proteasome
26S subunit and ubiquitin-conjugating enzyme E2 were
represented, a calcium-binding protein, calreticulin, was
found, and voltage-dependent anion channel 1 and 2 proteins were found.
In conclusion, the majority of NT pregnancies in cattle are lost around the time of placentation and placental
abnormalities are frequently associated with NT pregnancies (De Sousa et al., 2001; Hill et al., 2002; Hashizume
et al., 2002; Powell et al., 2004; Chae et al., 2006; Arnold
et al., 2006). An 18-day NT embryo–maternal interaction,
i.e., during the early implantation stage, had abnormalities
in the endometrial tissue that were already measurable in
terms of endometrial mRNA responses (Bauersachs et al.,

2009)—so what is the NT conceptus doing or not doing
to cause this? Aberrant expression of annexin proteins
are probably pertinent to this question since they are
abundant in the placenta, speciﬁcally at the fetomaternal
interface (Myatt et al., 1992; Kristoffersen and Matre, 1996;
Bogic et al., 1999), and because annexins, or their biologically active externalized soluble peptide fragments, have
effects on so many diverse biological processes, including
tissue immunomodulation, apoptosis (annexin V), inhibition of placental blood coagulation (annexin V), mediation
of intracellular membrane fusion (annexins I and II and
synexin or annexin VII), signal transduction for cell differentiation, extracellular matrix remodeling via activation
of plasminogen and, indirectly, matrix metalloproteinases
(MMPs), and prostaglandin synthesis regulation via high
afﬁnity, Ca2+ -dependent, binding of phospholipids (Creutz,
2003; Buckland and Wilton, 2003).
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